PressDigest

Teva weighs Mylan bid to disrupt Perrigo deal

Teva Pharmaceutical Industries, the Israeli generic drug maker, is weighing a takeover offer for rival Mylan to thwart the latter’s proposed $28.9bn acquisition of Ireland-based Perrigo, The Wall Street Journal has learnt.

WSJ Logo
JPMorgan to Pay $330 Million Over 1MDB TransactionsExternal link

JPMorgan to Pay $330 Million Over 1MDB Transactions